Tonsillitis, often termed acute pharyngotonsillitis when the pharynx is involved, is an inflammatory condition of the palatine tonsils that commonly presents with sore throat, fever, odynophagia (painful swallowing), and cervical lymphadenopathy. Clinically, patients may report malaise, headache, and loss of appetite. On examination, clinicians typically observe tonsillar erythema, swelling, and exudates, though the specific appearance does not reliably distinguish viral from bacterial etiologies. Because management differs—particularly regarding antibiotic use—accurate assessment is a core clinical priority.
The most frequent cause of tonsillitis is viral infection, including adenovirus, rhinovirus, influenza viruses, and Epstein-Barr virus. Viral tonsillitis often coexists with symptoms such as cough, coryza (runny nose), hoarseness, conjunctivitis, or oral ulcerations, which can support a viral diagnosis. Conversely, Group A beta-hemolytic Streptococcus (GAS, Streptococcus pyogenes) is the major bacterial cause associated with complications like acute rheumatic fever and, less commonly, post-streptococcal glomerulonephritis. GAS tonsillitis classically presents with abrupt onset sore throat, fever, tender anterior cervical nodes, and tonsillar exudate; however, overlap with viral presentations is common.
Pathophysiologically, GAS adheres to oropharyngeal epithelium and can produce a range of virulence factors that facilitate immune evasion and local inflammation. The resulting immune response contributes to erythema, swelling, and exudate formation. Importantly, the link between GAS and rheumatic fever is mediated by molecular mimicry: antibodies generated against streptococcal antigens may cross-react with host tissues, particularly cardiac structures. This is why prompt identification of suspected streptococcal infection and appropriate antibiotic therapy reduces both symptom duration and complication risk.
Diagnostic evaluation begins with clinical prediction tools. The Centor and McIsaac criteria incorporate factors such as tonsillar exudate, tender anterior cervical lymphadenopathy, absence of cough, fever, and age adjustment. While these tools estimate the probability of GAS, they are not definitive. Current evidence-based practice generally emphasizes microbiologic confirmation when the probability is intermediate or when symptoms suggest GAS, because the indiscriminate use of antibiotics contributes to resistance and exposes patients to adverse effects.
Testing typically includes a rapid antigen detection test (RADT) for GAS. RADTs have high specificity; a positive result strongly supports GAS infection. When RADT is negative, confirmatory throat culture may be recommended in children and adolescents due to the lower sensitivity of some RADTs and the consequence of missing GAS. In adults, culture confirmation may be less routinely required because GAS complications like rheumatic fever are rarer and baseline prevalence differs.
Treatment depends on the cause and severity. For confirmed or strongly suspected GAS tonsillitis, first-line therapy is penicillin or amoxicillin. Alternatives include cephalosporins for patients with non-anaphylactic penicillin allergy, and macrolides (or clindamycin) for those with severe beta-lactam allergy, guided by local resistance patterns. Antibiotics reduce contagiousness (often after 24 hours of effective therapy), shorten symptom duration modestly, and prevent immune-mediated complications.
Supportive care is central for both viral and bacterial cases. Analgesics such as acetaminophen or nonsteroidal anti-inflammatory drugs can address pain and fever. Adequate hydration, rest, and throat lozenges may improve comfort. Patients should be counseled about warning signs that suggest complications requiring urgent evaluation: peritonsillar abscess (characterized by “hot potato” muffled voice, unilateral swelling, uvular deviation, trismus), airway compromise, severe dehydration, or persistent high fever.
Complications of tonsillitis include spread to adjacent spaces (peritonsillar and retropharyngeal abscess), otitis media, sinusitis, and—in GAS cases—rheumatic fever or glomerulonephritis. Distinguishing uncomplicated tonsillitis from abscess is clinically important because abscess management may require drainage in addition to antibiotics and sometimes inpatient care.
Prevention strategies focus on reducing transmission, particularly in household and school settings. Respiratory hygiene, handwashing, avoiding close contact during acute illness, and not sharing utensils can lower spread. Patients with recurrent episodes may warrant further evaluation for alternative diagnoses such as chronic tonsillitis, infectious mononucleosis, or noninfectious etiologies (e.g., reflux). Recurrent streptococcal pharyngotonsillitis can prompt discussion of tonsillectomy in selected cases, based on episode frequency and documented GAS evidence.
In summary, tonsillitis is a common cause of acute sore throat, most often viral but sometimes due to GAS requiring targeted antibiotics. Clinical assessment supported by validated criteria, followed by RADT and/or culture when indicated, enables evidence-based treatment that improves outcomes and reduces complications. Source: [Herreras1class / X post: @Herreras1class]
Mrs. H: @LeahRay44 Go to Stockyards eat at Coopers BQQ across from @BillyBobsTexas eat tacos at Maestro Tacos. #breaking
— @Herreras1class May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
